Using patient-derived stem cell models to determine the molecular mechanisms driving NF1-associated neurodevelopmental disorders

This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $494,851 to the Murdoch Children's Research Institute (MCRI) in Australia to conduct research aimed at determining the molecular mechanisms driving NF1-associated neurodevelopmental disorders. The project will leverage patient-derived stem cell models to investigate these mechanisms. The award period runs from August 1, 2024 to July 31, 2027. MCRI, a non-profit medical research organization, has received multiple federal grants from agencies like the Defense Health Agency and National Institute of Allergy and Infectious Diseases for research on diverse topics including neurodevelopmental disorders, immunology, and rare genetic conditions. This specific award demonstrates MCRI's expertise in conducting advanced scientific investigations and collaborating with prominent U.S. research institutions through sub-grant arrangements.